Can-Fite BioPharma Rings The Opening Bell at NYSE

Can-Fite Biopharma Ltd - $CANF |


On Dec. 5, Can-Fite BioPharma (CANF)  celebrated rang the Opening Bell at the New York Stock Exchange to celebrate the Petach Tikva, Israel-based company's recent listing on the NYSE MKT. CEO Dr. Pnina Fishman was joined by key members of the company's management team and their guests for the momentous ceremony. Can-Fite is a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases. Be sure to read Equities.com's interview with Dr. Fishman here to learn more about Can-Fite's strategic focus and goals going forward.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel) 1.85 0.03 1.37 7,316
BMQCF Bank of Montreal Non Cumulative 5-Year Rate Reset n/a n/a n/a 0

Comments

Emerging Growth

MGX Minerals Inc.

MGX Minerals is a diversified Canadian mining company listed on the Canadian Securities Exchange. MGX is engaged in the acquisition and development of industrial mineral deposits in western Canada that…

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…